Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation

Clinical trial NCT00227370 · COMPLETED

Trial details

NCT number: NCT00227370
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2003-07-01
Primary completion: 2008-04-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.